SBP solbec pharmaceuticals limited

re: yuk! to gdp your post on 7 June contradicts what you are now...

  1. 59 Posts.
    re: yuk! to gdp your post on 7 June contradicts what you are now telling us.

    "With all due respect you'd be nuts to sell now. Steve Carter is confident of achieving Orphan Drug status by the end of this year. Have a look at the FDA web site to understand what Orphan Drug status actually confers on a company. Among other things the company has only to take the drug in question to Phase II clinical trials for commercialization. The application is not without risk for Solbec but if they achieve it the share price won't be at these levels again.

    The options are exercisable at 20 cents and any managing director whose company stands to reap 30 million dollars from the exercise of these options will be working his fingers to the bone to ensure a positive outcome. As far as anyone can be certain, the options will be in the money by June 30th next year."
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.